Interventions in randomised controlled trials in surgery: issues to consider during trial design

Trials
N S BlencoweMembers of the MRC Hub for Trials Methodology Research Network Workshop

Abstract

Until recently, insufficient attention has been paid to the fact that surgical interventions are complex. This complexity has several implications, including the way in which surgical interventions are described and delivered in trials. In order for surgeons to adopt trial findings, interventions need to be described in sufficient detail to enable accurate replication; however, it may be permissible to allow some aspects to be delivered according to local practice. Accumulating work in this area has identified the need for general guidance on the design of surgical interventions in trial protocols and reports. Key issues to consider when designing surgical interventions include the identification of each surgical intervention and their components, who will deliver the interventions, and where and how the interventions will be standardised and monitored during the trial. The trial design (pragmatic and explanatory), comparator and stage of innovation may also influence the extent of detail required. Thoughtful consideration of surgical interventions in this way may help with the interpretation of trial results and the adoption of successful interventions into clinical practice.

References

Sep 2, 1999·Stroke; a Journal of Cerebral Circulation·G G FergusonH J Barnett
Jan 29, 2002·Journal of Epidemiology and Community Health·L RychetnikA Shiell
Jan 8, 2005·BMJ : British Medical Journal·P J DevereauxGordon H Guyatt
Aug 30, 2005·Lancet·K Slim
Dec 7, 2007·Implementation Science : IS·Christopher CarrollShashi Balain
Oct 1, 2008·BMJ : British Medical Journal·Peter CraigUNKNOWN Medical Research Council Guidance
Oct 24, 2008·BMJ : British Medical Journal·Rob Anderson
Apr 8, 2009·Journal of Clinical Epidemiology·Kevin E ThorpeKalipso Chalkidou
Jul 18, 2009·Statistical Methods in Medical Research·Rebecca Walwyn, Chris Roberts
Sep 29, 2009·Lancet·Jeffrey S BarkunJan Vandenbroucke
Sep 29, 2009·Lancet·Patrick L ErginaJan Vandenbroucke
Sep 29, 2009·Lancet·Peter McCullochJan Vandenbroucke
Apr 13, 2010·The New England Journal of Medicine·UNKNOWN United Kingdom EVAR Trial InvestigatorsMark J Sculpher
Aug 19, 2010·JAMA : the Journal of the American Medical Association·Elliott Bennett-GuerreroUNKNOWN SWIPE-1 Trial Group
Nov 10, 2011·JAMA : the Journal of the American Medical Association·William J PowersUNKNOWN COSS Investigators
Jan 11, 2013·BMJ : British Medical Journal·An-Wen ChanDavid Moher
Oct 17, 2013·BMJ : British Medical Journal·Natalie BlencoweJane Blazeby
Nov 5, 2013·Journal of Cardiothoracic and Vascular Anesthesia·Olympia PapachristofiLinda Sharples

❮ Previous
Next ❯

Citations

Feb 21, 2016·Lancet·Aneel Bhangu, Dion Morton
Jul 28, 2016·The British Journal of Surgery·N S BlencoweJ M Blazeby
Nov 5, 2016·Statistics in Medicine·Olympia PapachristofiLinda Sharples
Feb 1, 2017·Clinical Trials : Journal of the Society for Clinical Trials·Natalie S BlencoweJane M Blazeby
May 3, 2018·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·Alexander Engel
Jun 1, 2018·The Cochrane Database of Systematic Reviews·Camille HuaLaurence Le Cleach
Nov 2, 2017·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·UNKNOWN Yorkshire Surgical Research Collaborative
Sep 7, 2018·Statistics in Medicine·Hayley E JonesNicky J Welton
Jan 7, 2020·The British Journal of Surgery·R L MorleyR J Hinchliffe
Jun 24, 2020·The British Journal of Surgery·D P HarjiUNKNOWN LaCeS Collaborators
Oct 22, 2019·Annals of Surgery·Christian E OberkoflerInne Borel Rinkes
Oct 12, 2018·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Shankar LakshmanUNKNOWN Fibrin Sealant Grifols in Soft Tissue Surgery Study Clinical Investigation Group
Feb 8, 2019·Obesity Surgery·Sarfaraz J BaigUNKNOWN Indian Bariatric Surgery Outcome Reporting (IBSOR) Group
Aug 7, 2017·Acta neurochirurgica·I S MuskensM L D Broekman
Feb 27, 2021·Journal of the American College of Cardiology·Christoph P Hornik
Mar 29, 2021·Obesity Surgery·Andrew C CurrieJamie Kelly
Apr 4, 2020·Journal of the American College of Cardiology·Mario GaudinoStephen E Fremes

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

TIDieR
IDEAL

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.